Clinical Trials Insight: 700012951

Trial Profile

Clinical Trials Insight: 700012951

Phase of Trial: Phase I

Latest Information Update: 23 Aug 2006

At a glance

  • Drugs Vapendavir (Primary)
  • Indications Rhinovirus infections
  • Focus Adverse reactions
  • Sponsors Biota Pharmaceuticals
  • Most Recent Events

    • 23 Aug 2006 Status change
    • 21 Apr 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top